Conference on HIV Science (IAS 2025) concluded in Kigali after five dynamic days (July 13-17), delegates left with a mix of hope and concern--buoyed by scientific breakthroughs but unsettled by a ...

In patients who transitioned from injected SRLs to once-daily oral PALSONIFY, mean insulin-like growth factor 1 (IGF-1) levels remained stable with IGF-1 (mean ± SE) of 0.93 ± 0.22 at OLE baseline and ...

Title: CVN293, an Investigational Inhibitor of KCNK13 Targeting NLRP3-Mediated Neuroinflammation in Neurodegenerative Disease: A Phase 1 Study to Investigate the Safety, Tolerability, and ...

Poster #3 : Advancing buntanetap: comparative pharmacokinetic characterization of the original semi-crystalline with the novel crystalline form in animals and humans.

Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA) PR Newswire HONG KONG, June 8, 2025 ...

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress Provided by PR Newswire May 22, 2025, 2:20:00 PM ...

Their research findings and creative works are presented at international conferences, local symposia, and community events. From scholarly lectures to TED-style talks, from academic posters to ...

LONDON and NEW YORK, May 13, 2025-- MeiraGTx Holdings plc, a vertically integrated, clinical stage genetic medicines company, today announced the Company will exhibit four poster presentations at ...

Ascletis Announces Oral and Poster Presentations on ASC47, an Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate for Obesity at the 32nd European Congress on Obesity ...

Spyre Therapeutics Announces Poster Presentations at Digestive Disease Week (DDW) 2025 Including Up to Eight months of Follow-up from an Ongoing Phase 1 Trial of SPY001 By Spyre Therapeutics, Inc.

Outstanding student work will be showcased May 1 and 2 at Transformations: A Student Research and Creativity Conference. This year, a total of 96 students will showcase their work mentored by 47 ...

Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced its slate of seven scientific presentations, three oral and four in poster form, that have been accepted for the 28th Annual ...